Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 37 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/25/2008 First Published: 3/1/1997


1.		Phase III Randomized Study of Medroxyprogesterone Acetate Versus Observation for Prevention of Endometrial Pathology in Postmenopausal Women With Breast Cancer Treated With Adjuvant Tamoxifen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention, Treatment				Closed				18 and over				NCI				SWOG-S9630 CALGB-49901, SWOG-9630, S9630, NCT00002920

Last Modified: 1/21/2009 First Published: 4/1/1999


2.		Randomized Study of a Diet Rich in Vegetables, Fruit, and Fiber and Low in Fat in Women With Previously Treated Stage I, II, or III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention, Treatment				Closed				18 to 70 at time of diagnosis				NCI				UCSD-980919 UCSD-WHEL, NCI-G99-1508, NCT00003787

Last Modified: 1/8/2009 First Published: 7/1/1999


3.		Phase III Randomized Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				35 and over				NCI				NSABP-P-2 NCT00003906


4.		Women's Health Initiative (WHI)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Health services research, Natural history/Epidemiology, Prevention				Completed				50 to 79				NCI, NHLBI				114 NCT00000611

Last Modified: 5/1/1999


5.		Phase II Study of DiFluoroMethylOrnithine (DFMO) in Breast Dysplasia with Biomarker Abnormalities (Summary Last Modified 05/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				30-55 with exceptions				NCI				KUMC-HSC-6916-96 NCI-P97-0080

Last Modified: 3/1/1998


6.		Phase II Randomized, Double Blind, Placebo-Controlled Study of Eflornithine (DFMO) in Women with Breast Neoplasia (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				18 and over				NCI				UAB-9509 NCI-P97-0082

Last Modified: 6/1/1998 First Published: 11/1/1997


7.		Phase II Trial of Dietary Fatty Acids: Roles in Hormonally Mediated Cancers in Normal Premenopausal Women (Summary Last Modified 06/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				18-35				NCI				UMN-9509M10234 NCI-P97-0108

Last Modified: 12/28/2006 First Published: 11/1/1997


8.		Phase II Study of Fenretinide and Tamoxifen Prior to Definitive Surgery in Women With Breast Neoplasias (Summary Last Modified 05/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				Over 18				NCI				MDA-ID-94029 NCI-P97-0113, NCT00003099

Last Modified: 5/26/2005 First Published: 8/1/1998


9.		Phase II Study of Raloxifene as a Chemopreventive Agent for Premenopausal Women at High Risk for Developing Invasive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Completed				23 to 47				NCI				NCI-98-C-0123 MB-402, NCT00019500

Last Modified: 1/19/2009 First Published: 2/1/2000


10.		Phase II Randomized Study of Exemestane and Raloxifene in Postmenopausal Women With a History of Stage 0 (Ductal Carcinoma in Situ), I, II, or III Breast Cancer Who Have No Clinical Evidence of Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention, Treatment				Closed				18 and over				NCI				MSKCC-99017 NCI-G99-1662, NCT00004247

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute